Cargando…

Construction and validation of a nomogram for non small cell lung cancer patients with liver metastases based on a population analysis

Lung cancer is one of the most common malignancies in the United States, and the common metastatic sites in advanced non-small cell lung cancer (NSCLC) are bone, brain, adrenal gland, and liver, respectively, among which patients with liver metastases have the worst prognosis. We retrospectively ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Ruhan, Dai, Yunnan, Li, Xinyang, Zhu, Cuimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901853/ https://www.ncbi.nlm.nih.gov/pubmed/35256719 http://dx.doi.org/10.1038/s41598-022-07978-8

Ejemplares similares

Construction of a nomogram to predict the prognosis of non-small-cell lung cancer with brain metastases
por: Huang, Zhangheng, et al.
Publicado: (2020)

Construction and validation of prognostic nomograms for elderly patients with metastatic non‐small cell lung cancer
por: Sun, Haishuang, et al.
Publicado: (2022)

Development and validation of a nomogram for the prediction of brain metastases in small cell lung cancer
por: Li, Weiwei, et al.
Publicado: (2023)

The Construction and Validation of Nomogram to Predict the Prognosis with Small-Cell Lung Cancer Followed Surgery
por: Wu, Lei-Lei, et al.
Publicado: (2022)

Construction, Validation, and Visualization of Two Web-Based Nomograms to Predict Overall and Cancer-Specific Survival in Patients with Gastric Cancer and Lung Metastases
por: Zheng, Honghong, et al.
Publicado: (2021)

Predict Postoperative Anemia of Patients: Nomogram Construction and Validation
por: Dai, Yimin, et al.
Publicado: (2022)

Development and validation of a nomogram to assess postoperative venous thromboembolism risk in patients with stage IA non‐small cell lung cancer
por: Cai, Yongsheng, et al.
Publicado: (2022)

Construction and Verification of Nomogram Model for Lung Adenocarcinoma With ≤ 5 Bone-Only Metastases Basing on Hematology Markers
por: Meng, Chunliu, et al.
Publicado: (2022)

Construction and Validation of Prognosis Nomogram for Metastatic Lung Squamous Cell Carcinoma: A Population-Based Study
por: Liu, Yuting, et al.
Publicado: (2022)

Validation of Six Nomograms for Predicting Non-sentinel Lymph Node Metastases in a Dutch Breast Cancer Population
por: Dingemans, Siem A., et al.
Publicado: (2015)

Construction and Validation of a Recurrent Risk Nomogram Model for Non-Small Cell Lung Cancer within 1 Year after Radical Resection
por: Zeng, Dechuang, et al.
Publicado: (2022)

Development and internal validation of nomograms based on plasma metabolites to predict non‐small cell lung cancer risk in smoking and nonsmoking populations
por: Zhang, Xu, et al.
Publicado: (2023)

Development and validation of two prognostic nomograms for predicting survival in patients with non-small cell and small cell lung cancer
por: Xiao, Hai-Fan, et al.
Publicado: (2017)

Development and Validation of a Radiomics Nomogram for Liver Metastases Originating from Gastric and Colorectal Cancer
por: Li, Yuying, et al.
Publicado: (2023)

AIF-1, a potential biomarker of aggressive tumor behavior in patients with non-small cell lung cancer
por: Wang, Lingling, et al.
Publicado: (2022)

Construction of a prognostic signature of autophagy-related lncRNAs in non-small-cell lung cancer
por: Zhang, Xinyang, et al.
Publicado: (2021)

Construction and validation of a nomogram based on N6‐Methylandenosine‐related lncRNAs for predicting the prognosis of non‐small cell lung cancer patients
por: Xiao, Wenjing, et al.
Publicado: (2022)

Construction of a nomogram predicting the overall survival of patients with distantly metastatic non-small-cell lung cancer
por: Deng, Jianqing, et al.
Publicado: (2018)

Construction and validation of prognostic nomogram for metaplastic breast cancer
por: Li, Yongfeng, et al.
Publicado: (2022)

Construction and validation of a nomogram for patients with skin cancer
por: Ren, Jizhen, et al.
Publicado: (2021)

Differences of genomic alterations and heavy metals in non-small cell lung cancer with different histological subtypes
por: Mu, Die, et al.
Publicado: (2023)

Construction and Validation of Nomograms for Predicting the Prognosis of Uterine Leiomyosarcoma: A Population-Based Study
por: Meng, Yue, et al.
Publicado: (2020)

Survival benefit of resection surgery for lung adenocarcinoma with bone metastases and a post-operative prognosis nomogram establishment and validation
por: Zhao, Hanqing, et al.
Publicado: (2022)

Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study
por: Jiang, Aimin, et al.
Publicado: (2021)

Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis
por: Shi, Huaqing, et al.
Publicado: (2023)

The development and validation of a nomogram for predicting brain metastases after chemotherapy and radiotherapy in male small cell lung cancer patients with stage III
por: Yang, Baihua, et al.
Publicado: (2023)

Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer
por: Wang, Tao, et al.
Publicado: (2019)

Construction and validation of a prognostic nomogram for locally recurrent rectal cancer: a population-based study
por: Huang, Xiao, et al.
Publicado: (2023)

Establishment and Validation of Nomogram Model Integrated With Inflammation-Based Factors for the Prognosis of Advanced Non-Small Cell Lung Cancer
por: Huang, Zhiliang, et al.
Publicado: (2020)

Nomogram Predicting the Survival of Young-Onset Patients with Colorectal Cancer Liver Metastases
por: Cheng, Xiaofei, et al.
Publicado: (2022)

Computer Tomography Radiomics-Based Nomogram in the Survival Prediction for Brain Metastases From Non-Small Cell Lung Cancer Underwent Whole Brain Radiotherapy
por: Zhang, Ji, et al.
Publicado: (2021)

Development and Validation of a Prognostic Nomogram for Lung Adenocarcinoma: A Population-Based Study
por: Xie, Bin, et al.
Publicado: (2022)

Development and validation of radiomics nomograms for preoperative prediction of characteristics in non-small cell lung cancer and circulating tumor cells
por: Wang, Yang, et al.
Publicado: (2023)

Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort
por: Wang, Qing, et al.
Publicado: (2022)

Multisequence MRI-based radiomics nomogram for early prediction of osimertinib resistance in patients with non-small cell lung cancer brain metastases
por: Lv, Xinna, et al.
Publicado: (2023)

Construction and validation of a nomogram for predicting cancer-specific survival in hepatocellular carcinoma patients
por: Liu, Kang, et al.
Publicado: (2020)

Construction and validation of a nomogram of risk factors for new-onset atrial fibrillation in advanced lung cancer patients after non-surgical therapy
por: Chen, Jindong, et al.
Publicado: (2023)

Construction of a Nomogram Based on lncRNA and Patient’s Clinical Characteristics to Improve the Prognosis of Non-Small Cell Lung Cancer
por: Wang, Helin, et al.
Publicado: (2022)

Construction of Nomograms for Predicting Lung and Bone Metastases in Patients with Intrahepatic Cholangiocarcinoma and Identification of Patients Who Can Benefit from Chemotherapy
por: Shi, Ning, et al.
Publicado: (2020)

Construction and validation of a nomogram to predict the overall survival of small cell lung cancer: a multicenter retrospective study in Shandong province, China
por: Song, Ziqian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qob8c55abueeuor32b9s26c0ij